Results 31 to 40 of about 12,047 (282)

Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals [PDF]

, 2014
Introduction: Larger populations at risk, broader use of antibiotics and longer hospital stays have impacted on the incidence of Candida sp. bloodstream infections (CBSI).Objective: To determine clinical and epidemiologic characteristics of patients with
Alvarado Matute, Tito, Colombo, Arnaldo L., Cornejo Juárez, Patricia, Cortés, Jorge, Corzo León, Dora E., Echevarría, Juan I., Guzmán Blanco, Manuel, Macías, Alejandro E., Nucci, Marcio, Ostrosky Zeichner, Luis, Ponce de León, Alfredo, Ponce de León, Alfredo, Queiroz Telles, Flavio, Santolaya de Pablo, María Elena, Sifuentes Osornio, José, Thompson Moya, Luis, Tiraboschi, Iris Nora, Zurita, Jeannete   +17 more
core   +14 more sources

Evaluating the Efficacy and Safety of Anidulafungin and Caspofungin in Invasive Candida Infections in Intensive Care Units in India: A Prospective, Observational, Multicenter, Open-Label Study. [PDF]

Cureus
Mehta Y, Rao PV, Mahajan R, Panackel C.
europepmc   +3 more sources

Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay [PDF]

Antimicrobial Agents and Chemotherapy, 2019
Echinocandins are the recommended first-line antifungals for treatment of invasive candidiasis. The increasing number of Candida glabrata strains resistant against echinocandins is an emerging health care concern.
Mansoureh Vatanshenassan, Amir Arastehfar, Teun Boekhout, Judith Berman, Cornelia Lass‐Flörl, Katrin Sparbier, Markus Kostrzewa   +6 more
openalex   +2 more sources

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

Pharmaceutics, 2022
Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time ...
M. Melhem, V. Coelho, C. A. Fonseca, L. Oliveira, L. Bonfietti, M. W. Szeszs, M. Magri, Francine S. Dorneles, H. Taguchi, D. V. S. Moreira, A. L. Motta, M. Batista, K. Kamei, M. Shikanai-Yasuda   +13 more
semanticscholar   +1 more source

Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study

The Journal of Critical Care Medicine, 2022
Introduction Invasive candidiasis (IC) in critically ill patients is a serious infection with high rate of mortality. As an empirical therapy, like antibiotics, the use of antifungals is not common in intensive care units (ICUs) worldwide.
Md. Jahidul Hasan, S. Neelotpol, R. Rabbani   +2 more
semanticscholar   +1 more source

Breakthrough Acute Necrotizing Invasive Fungal Rhinosinusitis by Alternaria alternata in a Patient with Acute Lymphoblastic Leukemia on Anidulafungin Therapy and Case-Based Literature Review

Journal of Fungi, 2022
Alternaria spp. have emerged as opportunistic pathogens particularly in immunosuppressed patients. A case of a breakthrough acute invasive fungal rhinosinusitis (AIFRS), caused by Alternaria alternata, is reported in a patient with acute lymphoblastic ...
Giorgos Tyrellis, Maria Siopi, D. Leventakou, A. Delides, P. Maragkoudakis, G. Korres, C. Apostolopoulou, Alina-Roxani Gouloumi, V. Pappa, S. Pournaras, I. Panayiotides, J. Meletiadis   +11 more
semanticscholar   +1 more source

Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer

Frontiers in Cellular and Infection Microbiology, 2021
The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings.
Elena De Carolis, Federica Marchionni, Marilisa La Rosa, Jacques F. Meis, Jacques F. Meis, Anuradha Chowdhary, Brunella Posteraro, Maurizio Sanguinetti, Maurizio Sanguinetti   +8 more
doaj   +1 more source

Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2

Journal of Biomolecular Structure and Dynamics, 2021
COVID-19, for which no confirmed therapeutic agents are available, has claimed over 48,14,000 lives globally. A feasible and quicker method to resolve this problem may be ‘drug repositioning’. We investigated selected FDA and WHO-EML approved drugs based
S. Dey, M. Saini, Chetna Dhembla, Shruti Bhatt, A. Rajesh, Varnita Anand, H. K. Das, S. Kundu   +7 more
semanticscholar   +1 more source

Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates

Journal of Antimicrobial Chemotherapy, 2022
Background Increased fluconazole and echinocandin resistance in Candida glabrata requires prompt detection in routine settings. A phenotypic test based on the EUCAST E.DEF 7.3.2 protocol was developed for the detection of fluconazole- and anidulafungin ...
P. Georgiou, M. Arendrup, J. Meletiadis
semanticscholar   +1 more source

In vitro anidulafungin activity against yeasts – system and disseminated mycosis pathogens

Онкогематология, 2015
We analyzed susceptibility to anidulafungin of yeasts clinical strains of Candida (14 species), Cryptococcus (1 species), Geotrichum (1 species), Rhodotorula (1 species) and Saccharomyces (1 species).
A. B. Kulko
doaj   +1 more source